Latest aggressive prostate cancer Stories
Hair Club for Men and Women Offers Free Hair & Scalp Analysis to Uncover Hair and Scalp Condition Boca Raton, Florida (PRWEB) September 30, 2014
A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment.
Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic spread of the cancer.
An international research team led by Weill Cornell Medical College investigators have discovered two inherited-genetic deletions in the human genome linked to development of aggressive prostate cancer.
The largest study ever to examine the association of dietary fats and prostate cancer risk has found what's good for the heart may not be good for the prostate.
In one of the first studies to focus exclusively on the outcomes after treatment for patients with high-risk prostate cancer,(http://www.mayoclinic.org/prostate-cancer/) researchers have found that surgery provides high survival rates.
Researchers at Wake Forest University Baptist Medical Center and colleagues have identified the first genetic variant associated with aggressive prostate cancer, proving the concept that genetic information may one day be used in combination with other factors to guide treatment decisions.
A new study from Harvard School of Public Health (HSPH) and Brigham and Women's Hospital researchers has found a strong association between the common sexually transmitted infection, Trichomonas vaginalis, and risk of advanced and lethal prostate cancer in men.
Researchers have made initial progress toward the development of a urine test that detects prostate cancer, according to a new report released Wednesday by the British journal Nature.
- Growing in low tufty patches.